144 related articles for article (PubMed ID: 7255525)
1. Some new 5-substituted benzylidene-1-phenyl-3-(2'-pyridinobutan-4'-yl) thiobarbituric acids as psychopharmacological agents.
Srivastava VK; Satsangi RK; Shankar K; Kishor K
Pharmazie; 1981 Apr; 36(4):252-3. PubMed ID: 7255525
[TBL] [Abstract][Full Text] [Related]
2. 2-(2'-Hydroxyphenyl)-4-aryl-1,5-benzodiazepines as CNS active agents.
Srivastava VK; Satsangi RK; Kishore K
Arzneimittelforschung; 1982; 32(12):1512-4. PubMed ID: 6891590
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some newer derivatives of substituted quinazolinonyl-2-oxo/thiobarbituric acid as potent anticonvulsant agents.
Archana ; Srivastava VK; Kumar A
Bioorg Med Chem; 2004 Mar; 12(5):1257-64. PubMed ID: 14980637
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase inhibitory and CNS activities of some quinazolinones.
Lata A; Satsangi RK; Srivastava VK; Kishor K
Arzneimittelforschung; 1982; 32(1):24-7. PubMed ID: 7199337
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of newer indolyl/phenothiazinyl substituted 2-oxo/thiobarbituric acid derivatives as potent anticonvulsant agents.
Archana ; Rani P; Bajaj K; Srivastava VK; Chandra R; Kumar A
Arzneimittelforschung; 2003; 53(5):301-6. PubMed ID: 12854356
[TBL] [Abstract][Full Text] [Related]
6. Search for newer substituted phenoxyacetylethyleneimines as possible CNS, MAO and anticonvulsant agents.
Shukla JS; Ahmad I
Pharmazie; 1981 May; 36(5):327-8. PubMed ID: 7267680
[TBL] [Abstract][Full Text] [Related]
7. Substituted quinazolones as potent anticonvulsants and enzyme inhibitors.
Shrimali M; Kalsi R; Dixit KS; Barthwal JP
Arzneimittelforschung; 1991 May; 41(5):514-9. PubMed ID: 1898422
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase inhibitory and anticonvulsant studies of substituted 1,4-benzodiazepines.
Shrimali M; Kalsi R; Parmar SS; Barthwal JP
Arzneimittelforschung; 1991 Feb; 41(2):101-3. PubMed ID: 2043168
[TBL] [Abstract][Full Text] [Related]
9. Newer formazans and tetrazolium indoles as potential CNS-active agents.
Sathi G; Gujrati VR; Nath C; Agarwal JC; Bhargava KP; Shanker K
Arzneimittelforschung; 1983; 33(9):1218-21. PubMed ID: 6685502
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and CVS activity of 1-(2,3, 2,5, 2,6 dichlorophenyl)-3-morpholinophenyl-5-substituted benzylidene-thiobarbituric acids (3-17).
Singh A; Misra VS
Pharmacol Res; 1989; 21(1):59-64. PubMed ID: 2726666
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and pharmacological analysis of new derivatives of tetrahydro-[1,3]-thiazine and 2-thiobarbituric acid.
Zawisza T; Matczak H; Kowalczyk-Bronisz SH; Jakóbiec T
Arch Immunol Ther Exp (Warsz); 1981; 29(2):235-48. PubMed ID: 7030266
[TBL] [Abstract][Full Text] [Related]
12. Newer phenothiazines as anticonvulsants and monoamine oxidase inhibitors.
Lata A; Satsangi RK; Srivastava VK
Pharmazie; 1982 Aug; 37(8):549-51. PubMed ID: 7146060
[TBL] [Abstract][Full Text] [Related]
13. The anticonvulsant and CNS activity of N-butyryl-N-butylurea in mice.
Dar MS; Zirvi K; Fakouhi T
Farmaco Sci; 1979 Nov; 34(11):936-44. PubMed ID: 553825
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
15. 1-N-substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: synthesis and evaluation as MAO inhibitors.
Gökhan N; Yeşilada A; Uçar G; Erol K; Bilgin AA
Arch Pharm (Weinheim); 2003 Aug; 336(8):362-71. PubMed ID: 14502756
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and monoamine oxidase inhibitory activities of 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-1H-pyrazole derivatives.
Palaska E; Aydin F; Uçar G; Erol D
Arch Pharm (Weinheim); 2008 Apr; 341(4):209-15. PubMed ID: 18266289
[TBL] [Abstract][Full Text] [Related]
17. Some new 2-aryloxymethyl-3-alpha-substituted carboxymethyl-6,8-substituted-4-quinazolones as possible anticonvulsants.
Husain MI; Singh E
Pharmazie; 1982 Jun; 37(6):408-10. PubMed ID: 7122679
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
Hassan SY; Khattab SN; Bekhit AA; Amer A
Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel 2,5-disubstituted 1,3,4-thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies.
Rajak H; Deshmukh R; Aggarwal N; Kashaw S; Kharya MD; Mishra P
Arch Pharm (Weinheim); 2009 Aug; 342(8):453-61. PubMed ID: 19565600
[TBL] [Abstract][Full Text] [Related]
20. Possible psychopharmacological agents. Part 7: Synthesis and CNS activity of some fluorinated 2,4,7/8-trisubstituted-3H-1,5-benzodiazepinium monoperchlorates.
Joshi KC; Pathak VN; Arya P; Chand P
Pharmazie; 1979 Nov; 34(11):718-20. PubMed ID: 545340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
